KALA BIO, Inc.

KALA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001479419

SEC filings (opens in a new tab)

No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding KALA BIO, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of KALA: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	88	4	70	−14
Shares	24.4M	137.8K	7.52M	−16.7M (−69.0%)
Value	$33.7M	$190.0K	$2.27M	−$31.2M (−93.2%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held KALA BIO, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to KALA in Q2 2022
Institution	Shares	Value	% of portfolio
Ergoteles LLC	219,461	$66.0K	0.00%
Man Group plc	–	$14.0K	0.00%
Two Sigma Investments, LP	41,442	$12.0K	0.00%
HRT Financial LP	38,944	$11.0K	0.00%
Qube Research & Technologies Ltd	31,319	$9.00K	0.00%
Squarepoint Ops LLC	15,977	$5.00K	0.00%
Peapack Gladstone Financial Corp	13,675	$4.00K	0.00%
Creative Planning	14,200	$4.00K	0.00%
JustInvest LLC	14,360	$4.00K	0.00%
Northwestern Mutual Wealth Management Co	2,000	$1.00K	0.00%
Credit Suisse AG	26	$0	0.00%
Investors Asset Management of Georgia Inc	500	$0	0.00%
Simplex Trading, LLC	2,667	$0	0.00%

Sold out (27)

Institutions that held KALA BIO, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of KALA in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Ra Capital Management, L.P.	10,874,613	$15.0M
Graypoint LLC	487,106	$672.0K
Nuveen Asset Management, LLC	162,134	$250.0K
Bridgeway Capital Management, LLC	175,000	$242.0K
Charles Schwab Investment Management Inc	112,888	$156.0K
State Board of Administration of Florida Retirement System	83,483	$115.0K
MAI Capital Management	72,500	$100.0K
Rhumbline Advisers	68,051	$94.0K
Alliancebernstein L.P.	55,700	$77.0K
Algert Global LLC	39,416	$54.0K
D. E. Shaw & Co., Inc.	29,559	$41.0K
Deutsche Bank AG	28,161	$39.0K
American International Group, Inc.	24,325	$34.0K
Two Sigma Advisers, LP	23,600	$33.0K
Barclays PLC	22,239	$31.0K
Mirabella Financial Services LLP	22,100	$30.0K
California State Teachers Retirement System	21,331	$29.0K
Voya Investment Management LLC	18,304	$25.0K
LPL Financial LLC	17,519	$24.0K
Two Sigma Securities, LLC	16,838	$23.0K
Invesco Ltd.	15,671	$22.0K
Tower Research Capital LLC (TRC)	11,580	$16.0K
Amalgamated Bank	7,531	$10.0K
Ameritas Investment Partners, Inc.	3,497	$5.00K
Oregon Public Employees Retirement Fund	2,454	$3.00K
The PNC Financial Services Group, Inc.	216	$0
Capital Advisors, Ltd. LLC	80	$0

Not filed for Q2 2022 yet (4)

Institutions that held KALA BIO, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KALA in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Susquehanna Fundamental Investments, LLC	78,099	$108.0K
Parametric Portfolio Associates LLC	38,156	$53.0K
Keystone Wealth Partners	14,000	$19.0K
Amalgamated Financial Corp.	7,531	$10.0K